MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 121 filers reported holding MYOVANT SCIENCES LTD in Q4 2022. The put-call ratio across all filers is 1.67 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,945,406 | +20.2% | 72,159 | -19.9% | 0.10% | +63.5% |
Q3 2022 | $1,618,000 | -22.7% | 90,089 | -3.4% | 0.06% | -58.3% |
Q3 2021 | $2,093,000 | +152.8% | 93,274 | +211.1% | 0.15% | +7.1% |
Q4 2020 | $828,000 | +107.5% | 29,981 | +5.6% | 0.14% | +76.2% |
Q3 2020 | $399,000 | – | 28,400 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NovaQuest Capital Management, L.L.C. | 3,474,645 | $53,926,000 | 68.07% |
Eventide Asset Management | 4,126,131 | $64,038,000 | 1.80% |
VHCP Management III, LLC | 455,255 | $7,066,000 | 1.40% |
Ghost Tree Capital, LLC | 450,000 | $6,984,000 | 1.33% |
Cormorant Asset Management, LP | 2,000,000 | $31,040,000 | 1.24% |
Bellevue Group AG | 4,815,109 | $74,730,000 | 1.18% |
Values First Advisors, Inc. | 72,417 | $1,124,000 | 1.08% |
Parkman Healthcare Partners LLC | 99,413 | $1,543,000 | 0.44% |
Matisse Capital | 32,750 | $508,000 | 0.36% |
VHCP Management II, LLC | 76,768 | $1,191,000 | 0.31% |